Sign Up for Bullseye Daily Alerts
Subscribe to our newsletter to get our newest articles instantly!
I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…
Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a…
AI is shaking up healthcare — cutting costs, speeding diagnoses, and transforming entire fields. From virtual…
Welcome to the biotech jungle, where the vines are thick, the stakes are high, and the…
Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market…
I’ve always been fascinated by space… I grew up on Dune, 2001:…
Retail investors crushed it in April 2025 — buying when hedge funds…
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt…
Consumers Are Scared, and That Means — Opportunity! The headlines have been…
Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…
Consumers Are Scared, and That Means — Opportunity! The headlines have been impossible to miss: In…
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…
BioNTech (BNTX) is the biotech jungle’s speedy cheetah, sprinting at $95.50 (TipRanks) with a $35 billion market cap as of…
Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…
Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle gym of thrills, spills,…
Sign in to your account